article thumbnail

RLS Radiopharmacies Partners with Eckert and Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

Imaging Technology

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

article thumbnail

Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment

Imaging Technology

milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc. This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

American Society for Radiation Oncology (ASTRO) to Host Annual Meeting in Washington, DC, Sept. 29-Oct. 2

Imaging Technology

milla1cf Fri, 05/17/2024 - 18:43 May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's ( ASTRO ) 66th Annual Meeting, which will be held at the Walter E. September 29 – October 2, 2024. Washington Convention Center in Washington, D.C.,

article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

year over year, according to the newly published IMV 2024 PET Market Summary Report. In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. IMV's 2024 PET Market Summary Report explores market trends in U.S. Davin Korstjens.

PET Scan 115
article thumbnail

CMS Assigns Accretive Reimbursement for RefleXion’s Breakthrough SCINTIX Therapy

Imaging Technology

milla1cf Fri, 01/12/2024 - 11:09 January 12, 2024 — RefleXion Medical , Inc., 1, 2024, to describe SCINTIX therapy. The first code, C9794, defines a separate pre-treatment procedure in which radiopharmaceutical emissions data is collected for use in creating the SCINTIX treatment delivery plan.

article thumbnail

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Imaging Technology

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 to Curadh for use in its pioneering molecularly targeted radiation (MTR) programs for the treatment of common lethal tumors. “We

Medical 91
article thumbnail

University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients

Imaging Technology

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. Because there is no “typical” hospital or laboratory and many variables exist (e.g.,

Hospital 103